Y-Intercept (HK)’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.35M Buy
+14,437
New +$5.1M 0.12% 209
2026
Q1
– Sell
-10,667
Closed -$2.93M – 2114
2025
Q4
$2.93M Buy
+10,667
New +$2.92M 0.07% 435
2025
Q3
– Sell
-14,874
Closed -$3.25M – 2109
2025
Q2
$3.25M Buy
14,874
+6,676
+81% +$1.43M 0.08% 375
2025
Q1
$1.84M Buy
+8,198
New +$2.26M 0.12% 215
2024
Q3
– Sell
-5,187
Closed -$1.71M – 1867
2024
Q2
$1.71M Buy
+5,187
New +$1.83M 0.09% 290
2023
Q4
– Sell
-2,597
Closed -$974K – 1701
2023
Q3
$974K Buy
2,597
+1,402
+117% +$542K 0.1% 322
2023
Q2
$457K Buy
+1,195
New +$427K 0.05% 588
2023
Q1
– Sell
-3,740
Closed -$880K – 1591
2022
Q4
$880K Sell
3,740
-6,103
-62% -$1.45M 0.13% 237
2022
Q3
$2.42M Buy
+9,843
New +$3M 0.24% 112
2021
Q4
– Sell
-3,310
Closed -$1.4M – 922
2021
Q3
$1.4M Buy
+3,310
New +$1.4M 0.26% 120
2021
Q1
– Sell
-1,747
Closed -$489K – 830
2020
Q4
$489K Buy
+1,747
New +$490K 0.21% 158

Other funds holding WST

Y-Intercept (HK)'s WST Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in West Pharmaceutical (WST) in Q3 2026: 14,437 shares worth $5.35M. The stake represents 0.12% of the portfolio and ranks #209 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in WST as recently as Q4 2025.

Y-Intercept (HK) first reported a position in WST in Q4 2020 and has held it in 11 quarters since. 430 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Y-Intercept (HK) held 14,437 shares of West Pharmaceutical worth $5.35M as of Q3 2026.
  • West Pharmaceutical was a new Y-Intercept (HK) position in Q3 2026.
  • West Pharmaceutical made up 0.12% of Y-Intercept (HK)'s portfolio in Q3 2026, its #209 holding.
  • Y-Intercept (HK) first reported a position in West Pharmaceutical in Q4 2020 and has held it in 11 quarters since.
  • 430 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.